Cognitive Neurology Unit Clinical Registry

Diminishing Accelerated Long-term Forgetting in Mild Cognitive Impairment

NCT05289804 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease

NCT05063539 ·Status: COMPLETED ·Phase: PHASE2

Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies

NCT04699786 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Prospective Cohort Study of Patients With Early Alzheimer's Disease Treated With Lecanemab

NCT06741553 ·Status: RECRUITING

Therapeutic Efficacy of Monoclonal Antibody Drugs for Alzheimer's Disease Based on PET Research

NCT07152418 ·Status: NOT_YET_RECRUITING

A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease

NCT01767311 ·Status: COMPLETED ·Phase: PHASE2

A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

NCT02565511 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers

NCT00329082 ·Status: COMPLETED ·Phase: PHASE2

Effect of LY2062430 on the Progression of Alzheimer's Disease

NCT00905372 ·Status: COMPLETED ·Phase: PHASE3

Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo

NCT02957682 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease

NCT03462121 ·Status: COMPLETED ·Phase: PHASE2

Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment

NCT00149175 ·Status: COMPLETED

A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease

NCT03518073 ·Status: COMPLETED ·Phase: PHASE2

A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease

NCT00291421 ·Status: COMPLETED

A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

NCT03887455 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Feasibility of Lecanemab Registry and Clinical Outcome Measures

NCT06285448 ·Status: ENROLLING_BY_INVITATION

A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

NCT04971733 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study

NCT01230853 ·Status: COMPLETED ·Phase: PHASE1

BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.

NCT02337907 ·Status: COMPLETED ·Phase: PHASE2

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.

NCT04623242 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects

NCT00456417 ·Status: COMPLETED ·Phase: PHASE1

Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

NCT03721705 ·Status: COMPLETED ·Phase: PHASE3

A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease

NCT01224106 ·Status: COMPLETED ·Phase: PHASE3

A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease

NCT06566170 ·Status: RECRUITING

Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease

NCT02811653 ·Status: UNKNOWN ·Phase: NA